Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Warning Letter Nosedive: US FDA Writes Fewest Quality-Related Missives Since 2002; Agency Isn't Sure Why

Mar 28 2017

• By Shawn M. Schmitt

Vintage inscription made by old typewriter, warning

Related Content

Compliance 360° Part 5: Medical Device 483s – US FDA's Top 5 Observations

Mar 06 2017

Compliance 360° Part 7: Factors Feeding Your Inspection Cycle – A New Paradigm

Mar 20 2017

Compliance 360° Part 8: Patient Influence On US FDA’s Enforcement Strategy

Mar 27 2017

Where Are The Warning Letters?

Aug 12 2015

Domestic, Foreign Manufacturers Achieve Virtual Quality-Related FDA Warning Letter Parity; Missive-Counting Methodologies Explained

Mar 28 2016

FDA Finalizes Post-Market Benefit-Risk Guidance

Dec 30 2016

Additional Topics

United States Warning Letters Compliance FDA Quality Quality Control Medical Device

More from US FDA Warning Letters

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window